http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104042837-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7008 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-8945 |
| filingDate | 2014-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2017-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2017-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104042837-B |
| titleOfInvention | A kind of pharmaceutical composition for bone and osteoarticular retrograde affection |
| abstract | A kind of pharmaceutical composition for being used to prevent and treat bone and osteoarticular retrograde affection, is formulated by D aminoglucose sulfates, red deer bone meal, radix cyathulae, the rhizome of davallia, the red sage root, the fruit of Chinese wolfberry, Chinese yam, the root of kudzu vine, hawthorn, peppermint.According to the etiology and pathogenesis feature of disease, the pharmaceutical composition is led to treating a disease by looking into both its root cause and symptoms, benefit is combined into the basic rules for the treatment of, there is good therapeutic action to degenerative osteoarthropathy and osteoporosis, meet both diseases in middle-older patient usually and the clinical practice deposited, overcome the single defect of existing product effect. |
| priorityDate | 2014-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 68.